Navigation Links
CAD in Medical Technology

iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix

NASHUA, N.H., June 19 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced it has initiated a clinical study for Colon CAD, its virtual colonoscopy CAD product, in p...

iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product

NASHUA, N.H., Jan. 22 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced an agreement with ACR Image Metrix to conduct a multi-reader clinical study of iCAD's CT C...

ACRIN Study Endorses Virtual Colonoscopy - Validation for Colon CAD Software Maker Medicsight plc

NEW YORK, Oct. 3 /PRNewswire-FirstCall/ -- MGT Capital Investments, Inc. (Amex: MGT ), an investment company focused on the Healthcare Information Technology ("HCIT") sector, announced today that the ACRIN study endorses virtual colonoscopy for Medicsight PLC (subsidiary of MGT). Medicsight P...

SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine

...hether all patients with diabetes and multi-vessel cad might be better treated with optimal medical thera... the BARI-2D study enrolled a very small subset of cad patients with diabetes, SCAI looks forward to addi...owever, patients with type 2 diabetes mellitus and cad are at high risk for cardiovascular events, includ...

First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting

...t levels and reduction in hemolysis. Patients with cad suffer from an autoimmune attack on their red bloo...th eculizumab in a very limited number of aHUS and cad patients. These observations and other knowledge ...ts." Initial Experience with Eculizumab in cad A poster titled "Long-term Efficacy of the...

XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week

...focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). cad is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems...

Screening for Ischemia in Asymptomatic Patients With Type 2 Diabetes: Five- Year Outcomes in the DIAD Study

... to assess the prevalence of silent myocardial ischemia and discern whether cad screening should be offered to all people with type 2 diabetes. According t...verall, 1,123 diabetic patients without symptomatic or previously diagnosed cad were randomized to either screening with myocardial perfusion imaging or st...

XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention

...focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). cad is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems...

FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)

...ve in the SPECT dominated myocardial perfusion imaging market. The use of BFPET in conjunction with PET technology holds the promise to better quality cad diagnosis." About FluoroPharma FluoroPharma is a molecular imaging company engaged in the discovery and development of proprietary products for th...

Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format

...s shown to be associated with different degrees of cad risk. Over time, cad can weaken the heart muscle and lead to heart attack and arrhythmias. cad is the most common type of heart disease and is th...

XTENT Announces European Regulatory Update

...focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). cad is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems...

XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting

...focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). cad is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems...

XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week

...focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). cad is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems...

XTENT Announces First Quarter 2008 Financial Results

...focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). cad is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems...

FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)

...ery disease (CAD). BFPET, as a PET imaging tracer, may have a significant advantage due to its potential to improve the sensitivity and specificity of cad diagnosis and to provide information on myocardial mitochondrial damage. "This agent, if successful, should improve CAD diagnosis and follow-up of the...

FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)

...ET's continued safety in Phase II clinical trials. The PET technology we are studying today shows early promise and may hold the key to better quality cad diagnoses." Dr. Strauss is the Clinical Director of Nuclear Medicine at Memorial Sloan Kettering Cancer Center and Professor of Radiology at Cornell U...

Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection

...ogy Being Evaluated to Determine How Chest X-Ray cad Could Transform Common Radiological Procedure Into...n ongoing program to determine whether chest X-ray cad (computer-aided detection) can improve practical e...ogram is designed to determine whether chest X-ray cad can help identify hard to detect lung cancers at a...

XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System

...focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). cad is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems...

XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007

...focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). cad is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems...

ACC Presentation Indicates Interleukin-1 Gene Variants Determine Increased Risk for Coronary Artery Disease from Oxidized Phospholipids

...vels of OxPL or Lp(a) were associated with significantly increased risk for cad (P less than 0.01). This effect was strongly accentuated in patients less t...flammatory IL-1 genotypes, oxidation of phospholipids and predisposition to cad in younger individuals," said Sotirios Tsimikas, M.D., Associate Professor ...

Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal

...hown that the guidelines may not be universally effective at identifying a patients risk of cardiac events. In 1988, a study on cholesterol lipids and cad noted that 75 percent of patients who suffer myocardial infarctions have normal levels of HDL-C and LDL-C (Castelli, Can J Cardiol 1988 4A:5A). Thes...
Other Tags
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
(Date:12/10/2014)... -- You,ve been here before: you desperately need to sign ... site key or the answer to your secret question. What,s ... Today, Hoyos Labs , a digital infrastructure ... put an end to the frustration that comes with usernames, ... leverages a user,s smartphone to acquire his or her biometrics ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
(Date:12/19/2014)... 19, 2014 From November 24, 2014, ... for the year 2014 in its Goa retreat . ... Through the Indian winters, from November to March, Siddhi Yoga ... beach of Arambol, Goa. The Goa training sessions will conclude ... of yoga teacher training, the 10th intake is also a ...
(Date:12/19/2014)... This is a professional and in-depth study ... with a focus on the Chinese market. The report ... Gliquidone manufacturers and is a valuable source of guidance ... industry. , Firstly, the report provides a basic overview ... technology. Then, the report explores the international and Chinese ...
(Date:12/19/2014)... (HealthDay News) -- Being in good shape seems to reduce ... looked at data from more than 57,000 Americans, including more ... between 1991 and 2009. Those in the poorest shape ... blood pressure at the start of the study, compared to ... fitness. Of the more than 8,000 people diagnosed with ...
(Date:12/19/2014)... Amy Norton HealthDay Reporter ... born to moms who were exposed to high levels of ... of developing autism, a U.S. study suggests. Researchers found ... 1990 and 2002, those exposed to the most air pollution ... who later developed autism. And exposure during the third trimester, ...
(Date:12/19/2014)... (HealthDay News) -- Prostaglandin analogue eye drops -- a ... risk of vision loss in patients with the eye ... by David Garway-Heath, of the Moorfields Eye Hospital and ... more than 500 people newly diagnosed with open-angle glaucoma ... one of the leading causes of blindness. About ...
Breaking Medicine News(10 mins):Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 2Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 4Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 5Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 6Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2
Other Contents